2 Einträge |
Seite 1 / 1
![]() |
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer. |
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P |
The New England journal of medicine. doi: 10.1056/NEJMoa1911361 |
PMID: 31851799 |
Prognostic Significance of Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer. |
Tserpeli V, Stergiopoulou D, Londra D, Giannopoulou L, Buderath P, Balgkouranidou I, Xenidis N, Grech C, Obermayr E, Zeillinger R, Pavlakis K, Rampias T, Kakolyris S, Kasimir-Bauer S, Lianidou ES |
Cancers. 2021 Dec 21. pii: cancers14010004. doi: 10.3390/cancers14010004 |
PMID: 35008168 |
2 Einträge |
Seite 1 / 1
![]() |